Five Landmark Studies That Could Reshape Oncology at ASCO 26 – CancerWorld

Research Spotlight: Highlights from the ASCO Annual Meeting and Beyond

Jun 24, 2026 - By Anna Berkenblit, MD, MMSc Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit , PanCAN’s Chie

<![CDATA[What Were the Top Head and Neck Cancer Highlights at ASCO 2026?]]>

ASCO Day 3: Pancreatic cancer advance earns standing ovation; Akeso and Summit face disappointment

ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.

Lung Cancer Patients on Drug From China’s Akeso Lived Longer

Promising news announced #ASCO26 for patients with #lungcancer. Dr. Roy Herbst comments on ivonescimab, noting the initial study results fro

New drug for cancer patients with ‘limited’ treatment options enters clinical trial

Scientists have expressed ‘excitement’ over the potential new treatment for advanced adrenocortical carcinoma (ACC)

New cancer drug trial offers hope for patients with rare aggressive tumour

Hope has been offered to patients living with a rare and aggressive form of cancer.